Diabetes research and clinical practice · 2026
The 1-hour plasma glucose as a specific marker for early-phase insulin secretory defects in young adults with obesity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yuan Miaomiao, Zhao Shaoqian, Lu Chenxiao, Tong Yangyi, Shen Chongrong, Yin Nan, Cao Zhiwen, Zhang Zhenxi, Liu Ruixin, Wang Jiqiu, Zhang Yifei, Gu Weiqiong, Chen Yufei, Hong Jie
Аннотация
AIMS: To determine whether 1-hour plasma glucose (1-h PG) during an OGTT outperforms other glycemic markers (FPG, 0.5-h PG, 2-h PG, HbA1c) in identifying impairments in insulin secretion, sensitivity, and β-cell compensation.
METHODS: We analyzed 2178 Chinese young adults (18-40 years) with obesity (BMI ≥ 28 kg/m2) and without diabetes. Associations between glycemic markers and OGTT-derived indices were assessed using adjusted correlations, regression, and ROC analyses. In a subcohort (n = 495) with frequently sampled intravenous glucose tolerance test (FSIVGTT) data, markers were evaluated against minimal-model estimates of first-phase secretion (AIRg), insulin sensitivity (SI), and disposition index (DI).
RESULTS: 1-h PG showed superior performance over other glycemic markers for identifying early-phase insulin secretion defects. Among these markers, it demonstrated the strongest correlation with IGI30 (ρ = - 0.413) and the highest discriminatory accuracy (AUC = 0.702); this was supported by FSIVGTT-derived AIRg. For insulin sensitivity, 1-h PG correlated more strongly with the Matsuda index, whereas 2-h PG was more strongly associated with FSIVGTT-derived SI. Elevated 1-h PG (≥8.6 mmol/L) identified individuals with impairments across all traits.
CONCLUSIONS: 1-h PG is a specific physiological marker of early-phase insulin secretion defects, supporting its role in early phenotyping and risk stratification in young adults with obesity.
METHODS: We analyzed 2178 Chinese young adults (18-40 years) with obesity (BMI ≥ 28 kg/m2) and without diabetes. Associations between glycemic markers and OGTT-derived indices were assessed using adjusted correlations, regression, and ROC analyses. In a subcohort (n = 495) with frequently sampled intravenous glucose tolerance test (FSIVGTT) data, markers were evaluated against minimal-model estimates of first-phase secretion (AIRg), insulin sensitivity (SI), and disposition index (DI).
RESULTS: 1-h PG showed superior performance over other glycemic markers for identifying early-phase insulin secretion defects. Among these markers, it demonstrated the strongest correlation with IGI30 (ρ = - 0.413) and the highest discriminatory accuracy (AUC = 0.702); this was supported by FSIVGTT-derived AIRg. For insulin sensitivity, 1-h PG correlated more strongly with the Matsuda index, whereas 2-h PG was more strongly associated with FSIVGTT-derived SI. Elevated 1-h PG (≥8.6 mmol/L) identified individuals with impairments across all traits.
CONCLUSIONS: 1-h PG is a specific physiological marker of early-phase insulin secretion defects, supporting its role in early phenotyping and risk stratification in young adults with obesity.